Open access · OA
via Europe PMC
Study protocol for FAXAge: a randomized, controlled clinical trial of fasting and exercise to slow aging in humans.
Fals EB, Springborg EC, Berthelsen AB, Nyeman-Nielsen J, Larsen S, Scheibye-Knudsen M.
GeroScience · 2026
Epigenetic alterations
Dysbiosis
Chronic inflammation
Intermittent fasting
Exercise
Human
Preclinical / animal
Abstract
Biomarkers of aging, particularly DNA methylation-based clocks, have shown promise as tools to assess whether interventions may impact the rate of biological aging. Among possible interventions physical exercise has shown protective effects against many age-associated diseases, while time-restricted feeding (TRF) has shown metabolic benefits in preclinical models. The combined effect of exercise and TRF on aging biomarkers remains largely unexplored. In this 52-week four-armed, randomized, controlled trial (clinicaltrials.gov: NCT07207044) 240 healthy adults aged 65 and above will be allocated to four groups: combined cardio and strength training (EXE), TRF, combined EXE and TRF, or control. Participants will undergo assessments at baseline, 3, 6, and 12 months, with follow-ups at 2, 5, and 10 years. The primary outcome measure is Dunedin Pace of Aging DNA methylation age with secondary measures including RNA-sequencing, metabolomics, inflammatory markers, microbiome analysis, cognitive and physical measures. By deeply phenotyping participants, the Fasting And eXercise (FAXAge) study will provide novel insights into whether TRF, EXE, or a combination can slow or reverse biological aging in older adults.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s11357-026-02362-0
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
EB, F., EC, S., AB, B., J, N., S, L., & M., S. (2026). Study protocol for FAXAge: a randomized, controlled clinical trial of fasting and exercise to slow aging in humans. <em>GeroScience</em>. https://doi.org/10.1007/s11357-026-02362-0
Vancouver
EB F, EC S, AB B, J N, S L, M. S. Study protocol for FAXAge: a randomized, controlled clinical trial of fasting and exercise to slow aging in humans. GeroScience. 2026. doi:10.1007/s11357-026-02362-0.
BibTeX
@article{fals2026Studyp,
title = {Study protocol for FAXAge: a randomized, controlled clinical trial of fasting and exercise to slow aging in humans.},
author = {Fals EB and Springborg EC and Berthelsen AB and Nyeman-Nielsen J and Larsen S and Scheibye-Knudsen M.},
journal = {GeroScience},
year = {2026},
doi = {10.1007/s11357-026-02362-0},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Copenhagen 2025
Open access · US-GOV
FAXAGE: A Randomized, Controlled Clinical Trial Of Fasting And Exercise To Slow Aging In Humans
University of Novi Sad, Faculty of Sport and Physical Education 2023
Open access · US-GOV
The Effects of Drinking Hydrogen-rich Water for 6 Weeks on Exercise-related Biomarkers in Men and Women Over 50 Years Following Resistance Training Program: a Randomized Controlled Pilot Trial
Technical University of Munich 2024
Open access · US-GOV
Effect Of Daily Taurine Supplementation For 6 Months On Biological Age and Metabolic Biomarkers As Well As Physical Fitness In 55-75-year-old Women And Men: A Randomized Controlled Intervention Study
University Rovira i Virgili 2026
Open access · US-GOV
Effect of Action Observation Combined With Therapeutic Exercise on Balance and Falls in Community-Dwelling Adults ≥65: A Randomized Trial
Fundacion Miguel Servet 2021
Open access · US-GOV
Effect of an Individualized Combined Intervention (Vivifrail-Cogn) on the Rate of Falling of Frail Older Adults at Risk of Falling Living in the Community: a Multicenter Randomized Clinical Trial.
Guangzhou Patronus Biotech Co., Ltd. 2022
Open access · US-GOV